iovance.com (IOVA) - Volume dana dhuwit perusahaan

Simbol resmi perusahaan Iovance Biotherapeutics (IOVA)

High logistics and implementation costs for Amtagvi are weighing on margins for Iovance Biotherapeutics (IOVA). However, its status as a global pioneer in TIL therapy and personalized oncology creates a foundation for growth, despite the challenges of automating live tissue processing. The cash balance indicates a support level, with the metric currently standing at 0.38, which determines the issuer's current liquidity reserve.

IOVA - Cadangan dhuwit perusahaan Iovance ing rentang 04.07.2022 - 21.11.2026

Rincian analitis perusahaan Iovance Biotherapeutics

- rega saiki lan proyeksi nilai saham:
Pambiji fundamental perusahaan:Iovance Biotherapeutics Inc IOVA
Produk merek Iovance Biotherapeutics, Inc.

This metric measures the total volume of liquid assets, determining the issuer's ability to fund operations without raising external capital. By analyzing changes in cash holdings, an investor can identify resource depletion due to operating losses, which is critical for Iovance Biotherapeutics (IOVA), whose commercialization of cell therapy remains independent of economic cycles and relies exclusively on medical protocols.

Pesaing Iovance Biotherapeutics (IOVA)

Dhuwit awis perusahaan IBRX (ImmunityBio Corp)|Gunggung dana dhuwit perusahaan IMCR|Volume dana dhuwit perusahaan JANX (Janux Therapeutics, Inc.)|Sisa dhuwit perusahaan RCUS|zymeworks.com - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Tango Therapeutics Corp|Immatics N.V. (IMTX) - Dana dhuwit perusahaan|Xencor, Inc. - Sisa dhuwit perusahaan|CMPX (compasstherapeutics.com) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan Replimune Group Inc|Dana dhuwit perusahaan Lyell Immunopharma, Inc. (LYEL)|IPHA: Total volume dana dhuwit perusahaan|Pyxis Oncology - Dhuwit awis perusahaan|Compugen Limited (CGEN) - Cadangan dhuwit perusahaan|IO Biotech Inc - Volume dana dhuwit perusahaan|Aset likuid perusahaan Sutro Bio STRO|INKT: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Werewolf (HOWL)|Dana dhuwit perusahaan immixbio.com|Dhuwit awis lan setara dhuwit awis perusahaan ALXO (ALX Oncology)|Volume dana dhuwit perusahaan CUE|PDSB (PDS Biotechnology Corporation) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SONN (Sonnet BioTherapeutics Holdings)|Sisa dhuwit perusahaan MAIA|Liminatus - Volume dana dhuwit perusahaan|lavatherapeutics.com - Gunggung dana dhuwit perusahaan|NextCure (NXTC) - Dana dhuwit perusahaan|Leap Therapeutics Inc - Sisa dhuwit perusahaan|Dhuwit awis perusahaan INTS|Dana dhuwit perusahaan SNSE|Volume dana dhuwit perusahaan TOVX|GRTS - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan kinetabio.com KA|Sisa dhuwit perusahaan NEXI|turnstonebio.com - Volume dana dhuwit perusahaan|VCNX (Vaccinex, Inc) - Dhuwit awis lan setara dhuwit awis perusahaan|Harpoon Therapeutics (HARP) - Dana dhuwit perusahaan